Stock Events

Stock Events

Search...

Madrigal Pharmaceuticals (MDGL) Q4 2024 Earnings

31OctConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-7.54

-6.66

-5.79

-4.92

Details

Expected EPS

-6.748087

Actual EPS

-4.92

Surprise EPS

1.83

Surprise Percent

+27.09%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -4.92 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.